Cargando…
Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir
Microbiological response of SARS-CoV-2 to remdesivir in immunocompromised patients has not been evaluated. We present the case of a severely immunocompromised patient with persistent replication of SARS-CoV-2, who required different courses of remdesivir. Short courses of remdesivir might be insuffi...
Autores principales: | Camprubí, Daniel, Gaya, Anna, Marcos, Maria Angeles, Martí-Soler, Helena, Soriano, Alex, Mosquera, Maria del Mar, Oliver, Aina, Santos, Marta, Muñoz, Jose, García-Vidal, Carol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832789/ https://www.ncbi.nlm.nih.gov/pubmed/33359065 http://dx.doi.org/10.1016/j.ijid.2020.12.050 |
Ejemplares similares
-
Prolonged viral replication in patients with hematologic malignancies hospitalized with COVID-19
por: Garcia-Vidal, Carolina, et al.
Publicado: (2022) -
Clinical course of patients with severe COVID-19 pneumonia treated with remdesivir: A real-life study
por: Tejada, Diana, et al.
Publicado: (2022) -
Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients
por: Camprubí, Daniel, et al.
Publicado: (2020) -
Correction: Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients
por: Camprubí, Daniel, et al.
Publicado: (2022) -
Therapeutic Efficacy and Outcomes of Remdesivir versus Remdesivir with Tocilizumab in Severe SARS-CoV-2 Infection
por: Vulturar, Damiana-Maria, et al.
Publicado: (2022)